Company Profile

Vivo Cannabis Inc is a Canada-based company that provides cannabis products and services. The Company's principal business activity is the production and sale of medical and adult-use cannabis and cannabis products and providing cannabis-related medical information and services in Canada. The Company has a range of of premium brands, each targeting different customer segments, including Canna Farms, Beacon Medical, Fireside, and Lumina. Harvest Medicine, the Company's patient-centric network of medical cannabis clinics. The Company holds production and sales licenses from Health Canada and operates indoor and seasonal airhouse cultivation facilities. It offers pharmaceutical-grade products grown in small batches in Napanee, Ontario. Its Beacon Cannabis provides navigating medical cannabis using the Beacon Cannatypes classification system. The Company's wholly owned subsidiaries include ABcann Medicinals Inc (ABcann) and Canna Farms Limited (Canna Farms).

Employees

Sector

Pharmaceuticals

More about the company

10/02/25	Kensana Health Inc. cancelled the acquisition of ABcann Medicinals Inc from VIVO Cannabis Inc.	CI
17/12/24	Kensana Health Inc. entered into a share purchase agreement to acquire ABcann Medicinals Inc from VIVO Cannabis Inc. for CAD 5.5 million.	CI

10/02/25	Kensana Health Inc. cancelled the acquisition of ABcann Medicinals Inc from VIVO Cannabis Inc.	CI
17/12/24	Kensana Health Inc. entered into a share purchase agreement to acquire ABcann Medicinals Inc from VIVO Cannabis Inc. for CAD 5.5 million.	CI
03/04/23	MediPharm Labs Corp. Brief: Combined Company is owned approximately 73.1% by former MediPharm shareholders and approximately 26.9% by former VIVO shareholders	MT
03/04/23	MediPharm Labs Corp. Brief: Says Completed Acquisition of VIVO Cannabis Inc. and Confirmed Final Ownership Ratio	MT
01/04/23	MediPharm Labs Corp. completed the acquisition of VIVO Cannabis Inc. from directors and officers of VIVO and others.	CI
28/03/23	VIVO Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
28/03/23	VIVO Cannabis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
21/03/23	VIVO Cannabis Inc. - Shareholder/Analyst Call
22/12/22	MediPharm Labs Rises 7% As Says To Acquire VIVO Cannabis In All-Share Deal	MT
22/12/22	MediPharm Labs To Acquire VIVO Cannabis In All-Share Deal	MT
22/12/22	MediPharm Labs Corp. entered into a definitive arrangement agreement to acquire VIVO Cannabis Inc. from directors and officers of VIVO and others for CAD 11.2 million.	CI
14/11/22	VIVO Cannabis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
16/08/22	VIVO Cannabis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

03/04/23	MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio	AQ
18/02/23	VIVO Cannabis Inc. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with MediPharm Labs Corp.	AQ
22/12/22	IIROC Trade Resumption - VIVO	AQ
22/12/22	MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.	AQ
22/12/22	IIROC Trading Halt - VIVO	AQ

Manager	Title	Age	Since
Andreas Sander PRN	Corporate Officer/Principal	-	01/01/2019
Carole Chan HRO	Human Resources Officer	-	20/10/2020
Mariana Fonar LAW	General Counsel	-	21/06/2021

Director	Title	Age	Since
Holly Workman BRD	Director/Board Member	-	05/07/2021
Eric Shipman BRD	Director/Board Member	-	05/07/2021
Glen Ariel Huber BRD	Director/Board Member	59	17/12/2021

ABcann Global Corp Stock Toronto S.E.

Stocks

ABCN

CA00287W1032

Pharmaceuticals

Latest news: ABcann Global Corp

Press Releases: ABcann Global Corp

Managers and Directors: ABcann Global Corp

Alternative Medicine

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.86%	-2.91%	+39.01%	+113.17%	1,031B
JOHNSON & JOHNSON	-2.05%	-4.00%	+39.67%	+67.48%	638B
ABBVIE INC.	-0.88%	-2.15%	+6.16%	+74.99%	462B
MERCK & CO., INC.	-0.93%	-2.62%	+59.88%	+40.52%	359B
ROCHE HOLDING AG	-0.03%	-3.96%	+23.63%	+40.70%	335B
NOVARTIS AG	-1.58%	-0.76%	+13.50%	+26.44%	273B
ASTRAZENECA PLC	-2.02%	-2.97%	-3.25%	+9.88%	253B
AMGEN INC.	-2.72%	+0.90%	+37.26%	+53.85%	228B
GILEAD SCIENCES, INC.	-0.87%	-1.36%	+32.84%	+99.26%	185B
Average	-1.35%	-0.36%	+27.63%	+58.48%	418.21B
Weighted average by Cap.	-1.26%	-0.35%	+30.61%	+69.86%

End-of-day quote Toronto S.E.
- ^CAD	-